History
  • No items yet
midpage
ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC
2:04-cv-02355
| D.N.J. | May 14, 2013
Read the full case

Background

  • Sun moved in limine to exclude Dr. Vellturo's price erosion allocation opinions under Fed. R. Evid. 702/403.
  • Sun also moved to preclude Dr. Sullivan from testifying about price erosion as to Sun's actions under 702/403.
  • Dr. Vellturo opines 70% of divisible price erosion damages to Teva and 30% to Sun, based on market share of infringing pantoprazole sales.
  • Vellturo also uses market-share and market-entry-sequence methodologies to allocate damages.
  • Dr. Sullivan opines Teva bears no more than $299 million of price erosion and that Sun's actions caused additional erosion.
  • Court analyzes admissibility standards (Rule 702/403) and declines to exclude both experts in limine.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Admissibility of Vellturo's allocation method Vellturo's market-share method is valid and supported by precedent. Method flawed and relies on questionable assumptions; could confuse the jury. Denied; flaws not sufficient to exclude at this stage.
Admissibility of Sullivan's testimony on Sun's impact Sullivan offers specialized economic analysis of price erosion and Sun's role. Testimony lacks specialized basis and would mislead the jury. Denied; testimony held admissible as helpful and grounded in analysis.

Key Cases Cited

  • In re Mahurkar Patent Litig., 831 F. Supp. 1354 (N.D. Ill. 1993) (endorsed market-share approach for allocating price erosion damages)
  • Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (S. Ct. 1993) (gatekeeping reliability standard for expert testimony)
  • Kumho Tire Co. v. Carmichael, 526 U.S. 137 (S. Ct. 1999) (expanded Daubert to non-scientific expert testimony)
  • Daubert, 509 U.S. 579 (S. Ct. 1993) (gatekeeping function; admissibility depends on reliability and fit)
  • In re Paoli R.R. Yard PCB Litig., 35 F.3d 717 (3d Cir. 1994) (liberal qualification standard; tests reliability under Daubert framework)
  • Oddi v. Ford Motor Co., 234 F.3d 136 (3d Cir. 2000) (admissibility is not high bar; belief in valid reasoning suffices)
  • ZF Meritor, LLC v. Eaton Corp., 696 F.3d 254 (3d Cir. 2012) (link between facts and conclusions; reliability and fit prerequisites)
Read the full case

Case Details

Case Name: ALTANA PHARMA AG v. TEVA PHARMACEUTICALS USA INC
Court Name: District Court, D. New Jersey
Date Published: May 14, 2013
Docket Number: 2:04-cv-02355
Court Abbreviation: D.N.J.